Dr. Travis E Lalta, PhD
Claim this profileClinical Trials Travis E Lalta, PhD is currently running
More about Travis E Lalta, PhD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Travis E Lalta, PhD has experience with
- 10-Hz TMS To The DLPFC
- Sham TMS-DLPFC
Breakdown of trials Travis E Lalta, PhD has run
Nicotine Addiction
Smoking Addiction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Travis E Lalta, PhD specialize in?
Travis E Lalta, PhD focuses on Nicotine Addiction and Smoking Addiction. In particular, much of their work with Nicotine Addiction has involved treating patients, or patients who are undergoing treatment.
Is Travis E Lalta, PhD currently recruiting for clinical trials?
Yes, Travis E Lalta, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Travis E Lalta, PhD has studied deeply?
Yes, Travis E Lalta, PhD has studied treatments such as 10-Hz TMS to the DLPFC, Sham TMS-DLPFC.
What is the best way to schedule an appointment with Travis E Lalta, PhD?
Apply for one of the trials that Travis E Lalta, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.